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Abstract
Background: Isovolumic acceleration (IVA) is a new tissue Doppler parameter in the as-
sessment of systolic function of both left and right ventricles. It remains unaffected with the 
changes in pre- and after-load within the physiological range. The aim of our study was to 
assess the effect of mitral stenosis degree, which is determined by echocardiography, on the left 
ventricular (LV) function using IVA.
Methods: A total number of 62 patients with mitral stenosis (MS) and 32 healthy controls 
were examined. The severity of MS (mild, moderate, and severe) was determined on the basis of 
mitral valve area (MVA) and the mean diastolic mitral gradient findings. The peak myocardial 
velocities during isovolumic contraction, systole, early diastole and late diastole were measured 
by using tissue Doppler imaging (TDI).
Results: All TDI-derived global LV basal wall systolic (peak myocardial isovolumic contra-
ction velocity, peak myocardial systolic velocity and IVA), and diastolic velocities (peak early 
and late diastolic velocities) were significantly decreased in the patients with MS, compared 
to the healthy patients (p < 0.001, for all). However, IVA was not different when the degree of 
MS was evaluated (p = 0.114). In addition, IVA was not correlated with the MVA (r = 0.185, 
p = 0.150).
Conclusions: Left ventricular function is impaired in patients with MS regardless of the 
severity of the disease. (Cardiol J 2014; 21, 4: 442–448)
Key words: isovolumic acceleration, mitral stenosis, left ventricular function, 
tissue Doppler imaging
Introduction
Mitral stenosis (MS) still leads to significant 
morbidity and mortality worldwide [1]. The pre-
sence of impaired left ventricular (LV) systolic 
function, determined by M-mode and/or two-
-dimensional (2D) echocardiography (ECHO), is 
noted in 25–30% of the patients with MS [2–6]. Re-
cently, in the studies using tissue Doppler imaging 
(TDI) [7–9] and strain/strain rate imaging [10, 11], 
which are more sensitive methods compared to the 
conventional ECHO, the occurrence of subclinical 
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LV systolic dysfunction was confirmed even in MS 
patients with preserved ejection fraction (EF). The 
functional and/or myocardial factors, which cause 
impaired LV systolic function, are unclear. In the 
study of Lee and Lee [12], systolic dysfunction 
of LV was suggested to be associated with the 
severity of myocardial involvement in isolated 
mitral valve stenosis during the rheumatic attack, 
not with the degree of the MS demonstrated by 
ECHO. Furthermore, Sengupta et al. [8] showed 
that subclinical LV dysfunction improved following 
the percutaneous mitral valvuloplasty.
Isovolumic acceleration (IVA) is a new tissue 
Doppler parameter for the assessment of systo-
lic function of both left and the right ventricles 
[13, 14]. IVA is calculated as a ratio of tissue 
Doppler-derived peak myocardial velocity during 
isovolumetric contraction (IVV) divided by the 
acceleration time (AT). This parameter has been 
validated in a variety of experimental [13, 14] and 
clinical [15, 16] settings. IVA remains unaffected 
by the changes in the preload and afterload within 
the physiological range [13–16]. It can detect small 
changes in the contractile function and is well cor-
related with the invasive or noninvasive measures 
of LV dP/dt [13, 17].
Effect of the degree of mitral valve stenosis, 
which is determined by echocardiographic and he-
modynamic parameters, on LV function is not clearly 
evaluated. The aim of our study was to assess the 
effect of mitral valve stenosis degree, which is de-
termined by ECHO, on the LV function using IVA.
Methods
A total number of 94 subjects, 62 isolated mi-
tral valve stenosis patients with preserved LVEF 
and sinus rhythm (mean age 39 ± 8 years; 56 
[90.3%] females) and 32 healthy volunteers (mean 
age 36 ± 8 years; 56 [81.2%] females) were in-
cluded in our study. All the participants underwent 
both conventional echocardiography and TDI. The 
patients with MS were divided into three groups 
(mild, moderate and severe), based on their mitral 
valve area (MVA) determined by ECHO, and mean 
diastolic mitral gradients: 21 patients with mild ste-
nosis (MVA > 1.5 cm², mean gradient < 5 mm Hg), 
21 patients with moderate stenosis (MVA = 1– 
–1.5 cm2, mean gradient = 5–10 mm Hg) and 
20 patients with severe stenosis  (MVA < 1 cm2, 
mean gradient > 10 mm Hg).
Patients who had coronary artery disease, 
moderate to severe aortic and mitral regurgitation, 
aortic stenosis, hyperthyroidism, chronic obstructi-
ve pulmonary disease, atrioventricular conduction 
abnormality, left bundle branch block, segmental 
wall motion abnormalities, and severely calcified 
mitral valve structure were excluded in this study.
Written informed consent form was obtained 
from the patients following approval of the study 
by the institutional review board. The study was 
consistent with the Declaration of Helsinki.
Conventional echocardiographic examination
All the transthoracic echocardiographic (TTE) 
examinations were performed using GE vivid S6 
Vingmed system 5 (Norway, Horten) equipped 
with 2.5–4 MHz transducers. All the patients were 
examined in the left lateral and supine positions 
with 2D, M-mode, pulsed, and color flow Doppler 
ECHO. Single lead electrocardiogram was recorded 
continuously. An average of at least 5 cardiac cycles 
was obtained for all measurements.
M-mode measurements and conventional 
Doppler ECHO examinations were performed 
based on the criteria of the American Society of 
Echocardiography and European Society of Echo-
cardiography guidelines [18]. Left atrial (LA), LV 
end-systolic and end-diastolic dimensions were 
measured in the parasternal long-axis views. 
LVEF was estimated by Simpson’s rule. Peak and 
mean transmitral pressures were measured via 
continuous wave Doppler. MVA was measured 
planimetrically in 2D views from the parasternal 
short axis and using the pressure half-time method 
by applying continuous wave Doppler during apical 
4-chamber view of the mitral valve. The area was 
calculated by the mean value of 2 measurements 
[19]. Pulmonary artery systolic pressure (PASP) 
was estimated by continuous-wave Doppler ima-
ging using the Bernoulli equation [20].
Tissue Doppler imaging
Doppler tissue ECHO was performed using 
transducer frequencies between 3.5 to 4.0 MHz, by 
adjusting the spectral pulsed Doppler signal filters 
until a Nyquist limit of 15 to 20 cm/s was reached, 
and using the minimal optimal gain. Five consecu-
tive cycles were recorded with a frame rate greater 
than 150 fps. The monitor sweep speed was set at 
50 to 100 mm/s to optimize the spectral display of 
myocardial velocities. Every effort was made to 
align the pulsed wave cursor so that the Doppler 
angle of incidence was as close to 0 as possible to 
the direction of these walls. In the apical 4-cham-
ber view, the pulsed Doppler sample volume was 
subsequently placed at the level of LV lateral and 
septal basal wall at end-expiration [21].
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Peak myocardial IVV, peak myocardial sy-
stolic velocity (Sm), peak early and late diastolic 
velocities (e’ and a’), isovolumic AT, isovolumic 
contraction time (IVCT), isovolumic relaxation 
time (IVRT) and ejection time (ET) were mea-
sured. Myocardial performance index (MPI) was 
calculated as the sum of IVCT and IVRT divided by 
the ET. Myocardial acceleration during isovolumic 
contraction (IVA) was defined as the ratio of IVV 
divided by the AT (Fig. 1). 
All the ECHO evaluations were performed 
by 2 different investigators. In order to detect 
the intraobserver variability, the first investigator 
repeated the ECHO measurements of 20 patients 
and the second investigator measured TDI-derived 
parameters of 20 patients to detect interobserver 
variability.
Statistics analysis
Statistical analyses were performed using the 
SPSS software version 17. The variables were in-
vestigated using visual and analytical methods to 
determine whether they were normally distributed 
or not. Descriptive analyses were presented as 
mean ± standard deviation (SD) and categorical 
variables were shown as percentages. Groups 
were compared using the Student’s t-test, Mann-
-Whitney U test, one-way ANOVA, and Kruskal-
-Wallis test (MVA, mitral valve gradient, PASP, Sm, 
e’, a’, IVCT, IVRT, AT, IVV). Fisher’s exact or c2 
tests was used to compare different groups. Mann-
-Whitney U test or Tukey’s test was performed to 
determine the significance of pairwise differences 
using Bonferroni correction to adjust for multiple 
comparisons. Correlation analyses were derived by 
using Spearman test. An overall 5% type-I error 
level was used to infer statistical significance.
Results
Clinical properties
Parameters such as age, gender, body mass 
index, heart rate, systolic blood pressure, diastolic 
blood pressure, smoking, hypertension, and diabe-
tes mellitus were similar in both MS and healthy 
groups (Table 1). Of the MS patients, 52 were 
classified in New York Heart Association functional 
class I or II and 10 patients were in class III.
Conventional echocardiographic parameters
LVEF, LV end-diastolic and end-systolic dia-
meters were similar in both the patient and the 
control groups. As an expected result, LA diameter 
and PASP were significantly higher in the patients 
with MS. LA diameter in patients with mild and 
moderate MS was significantly lower than those of 
the patients with severe MS (p = 0.004); however, 
there was no significant difference between the 
Figure 1. Tissue Doppler imaging-derived IVV and AT obtained from left ventricular septal basal wall of patients with 
mitral stenosis; IVV — peak myocardial velocity during isovolumic contraction; AT — isovolumic acceleration time; 
IVA — myocardial acceleration during isovolumic contraction.
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patients with mild and moderate MS. There was 
a stepwise increase in the PASP and diastolic trans-
mitral gradients (maximum and mean) from mild to 
severe MS (p < 0.01 and p < 0.001, respectively). 
A stepwise decrease was found in the MVA from 
mild to severe MS (p < 0.001) (Table 1).
TDI velocities
All the TDI-derived global LV basal systolic 
(IVV, IVA, Sm) and diastolic velocities (e’, a’) were 
significantly decreased in the patients with MS 
compared to the healthy groups (p < 0.001, for all). 
In patients with MS, IVRT and MPI were signifi-
cantly higher than the control group (p < 0.001, 
p = 0.007, respectively) and the ET was lower in 
the control group (p = 0.018). The AT and IVCT 
were not different among the groups (p = 0.432, 
p = 0.119, respectively) (Table 2).
The IVA and Sm, which indicate LV systolic 
function, and MPI, which shows LV both systolic 
and diastolic function, did not differ among the 
3 MS groups (p = 0.114, p = 0.096 and p = 0.238, 
respectively). Excluding ET, time intervals such as 
AT, IVRT and IVCT were not different among the 
MS groups (p = 0.005, p = 0.922, p = 0.192 and 
p = 0.498, respectively). The IVV, e’ and a’ veloci-
ties in the patients with severe MS were signifi-
cantly lower than those of the patients’ with mild 
MS (p < 0.01, for all). However, there were no 
significant differences between the moderate and 
both mild and severe MS patients (p > 0.017). 
Agreement of intraobserver and interobserver 
variabilities were obtained for the IVA (4 ± 2% 
and 5 ± 3%, respectively).
Correlation between TDI velocities and 
conventional echocardiographic parameters
MVA was positively correlated with both LV 
diastolic velocities (e’ and a’) and IVV (p < 0.01, 
for all). However, there were no correlations be-
tween LV systolic velocities (IVA and Sm) and the 
MVA (p > 0.05). Mean transmitral gradient was 
weakly correlated with both IVV and e’ (p < 0.05). 
LA diameter and both systolic (IVV, IVA, Sm) and 
diastolic (e’, a’) velocities were shown to correlate 
(p < 0.001, for all). PASP was significantly associa-
Table 1. Demographic characteristics and conventional echocardiographic parameters of the patients 














Age [years] 40 ± 9 41 ± 7 36 ± 7 0.137 39 ± 8 36 ± 8 0.163
Gender (female) 20 (95.1%) 19 (90.59%) 17 (85%) 0.541 56 (90.3%) 26 (81.2%) 0.177
Body mass index [kg/m2] 29 ± 6 27 ± 3 27 ± 4 0.190 27 ± 5 28 ± 4 0.467
Systolic BP [mm Hg] 122 ± 12 115 ± 11 115 ± 9 0.076 117 ± 11 118 ± 10 0.677
Diastolic BP [mm Hg] 75 ± 10 71 ± 9 72 ± 8 0.360 72 ± 9 72 ± 8 0.812
Heart rate [beats/min] 80 ± 12 78 ± 10 80 ± 11 0.606 80 ± 12 78 ± 7 0.378
Current smoking 2 (9.5%) 1 (4.8%) 2 (10%) 0.790 5 (8.1%) 7 (21.9%) 0.060
Hypertension 5 (23.5%) 5 (23.8%) 2 (10%) 0.437 12 (19.4%) 4 (12.5%) 0.402
Diabetes mellitus 2 (9.5%) 1 (4.8%) 0 0.365 3 (4.8%) 0 (0%) 0.282
LVESD [mm] 30 ± 4 27 ± 4 29 ± 3 0.121 29 ± 4 28 ± 4 0.272
LVEDD [mm] 48 ± 5 47 ± 5 47 ± 5 0.738 47 ± 5 46 ± 5 0.184
LVEF [%] 63 ± 3 64 ± 2 64 ± 3 0.077 64 ± 3 65 ± 3 0.132
Left atrium diameter [mm] 39 ± 7 41 ± 4 45 ± 6* 0.003 42 ± 7 28 ± 4 < 0.001
Pulmonary artery systolic  
pressure [mm Hg]
33 ± 6 39 ± 10 50 ± 14 < 0.00** 40 ± 13 26 ± 4 < 0.001
Mean mitral valve area [cm2] 1.8 ± 0.1 1.3 ± 0.1 0.8 ± 0.1 < 0.001#
Transmitral diastolic gradient 
[mm Hg]:
Maximum 11 ± 4 16 ± 4 27 ± 8 < 0.001#
Mean 6 ± 2 9 ± 3 18 ± 6 < 0.001#
*p = 0.004 vs. mild and moderate; **p < 0.01 between all subgroups; #p < 0.001 between all subgroups; BP — blood pressure;  
LVEDD — left ventricular end-diastolic diameter; LVESD — left ventricular end-systolic diameter, LVEF — left ventricular ejection fraction
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ted with the parameters of LV systolic (IVV, IVA, 
Sm) and diastolic (e’, a’) function (p < 0.001, for 
all) (Table 3).
Discussion
In the light of these findings, it can be con-
cluded that TDI-derived systolic and diastolic 
velocities are significantly reduced in the patients 
with MS and LV systolic dysfunction occurs inde-
pendently from the severity of MS. To the best of 
our knowledge, this is the first study that evaluated 
the association between LV systolic velocities and 
severity of MS using TDI.
It is well known that MS affects the LV sy-
stolic function in various degrees. The probable 
causes can be listed as: chronically restricted 
LV filling due to the structural abnormalities in 
the mitral valve, increased afterload, myocardial 
involvement during rheumatic fever, extension 
of the scar process from the mitral valve into the 
adjacent posterior basal myocardium, restriction or 
tethering of the posterobasal myocardium by the 
scarred mitral apparatus, abnormal interventricular 
septal motion associated with the right-ventricular 
overload, and the decrease in LV compliance 
[2, 4]. Conventional ECHO methods such as M-mode 
and 2D ECHO can detect one fourth of the LV 
dysfunction in MS [2–6]. In recent years, the stu-
dies using TDI [3–5] and strain/strain rate imaging 
[6, 7] demonstrated the presence of subclinical LV 
systolic dysfunction, which was not detected with 
the conventional ECHO methods in pure MS pa-
tients with preserved EF. Since the gold standard 
Table 2. Tissue Doppler-derived myocardial systolic and diastolic velocities obtained from the left ven-
tricle.
Severity of mitral stenosis (MS)
Mild  
(n = 21)










IVV [cm/s] 5.6 ± 0.9 5.2 ± 0.8 4.9 ± 0.7* 0.018 5.2 ± 0.8 6.8 ± 1.2 < 0.001
Isovolumetric AT [ms] 22 ± 4 22 ± 4 22 ± 5 0.922 22 ± 4 23 ± 5 0.432
IVA [m/s2] 2.7 ± 0.8 2.5 ± 0.6 2.3 ± 0.6 0.114 2.5 ± 0.7 3.2 ± 0.9 < 0.001
Sm [cm/s] 7.9 ± 1.2 7.3 ± 1.3 7.2 ± 1.3 0.096 7.5 ± 1.3 9.6 ± 1.3 < 0.001
e’ [cm/s] 7.2 ± 3.2 5.4 ± 1.4 4.9 ± 1.0* 0.013 5.8 ± 2.3 13.1 ± 2.7 < 0.001
a’ [cm/s] 8.8 ± 1.9 7.8 ± 1.7 7.1 ± 1.3* 0.008 7.9 ± 1.8 10.1 ± 2.1 < 0.001
Isovolumic contraction time [ms] 64 ± 16 68 ± 16 63 ± 15 0.498 65 ± 15 70 ± 14 0.119
Isovolumic relaxation time [ms] 81 ± 22 90 ± 21 81 ± 26 0.192 84 ± 23 68 ± 13 < 0.001
Ejection time [ms] 294 ± 27 289 ± 24# 267 ± 28* 0.005 284 ± 29 298 ± 25 0.018
Myocardial performance index 0.50 ± 0.1 0.55 ± 0.1 0.55 ± 0.1 0.238 0.53 ± 0.1 0.47 ± 0.1 0.007
*p < 0.01 vs. mild; #p = 0.010 vs. severe; IVV — peak myocardial velocity during isovolumic contraction; AT — acceleration time;  
IVA — myocardial acceleration during isovolumic contraction; Sm — peak myocardial velocity during systole; e’ — peak myocardial velocity 
during early diastole; a’ — peak myocardial velocity during atrial contraction
Table 3. Correlation between tissue Doppler imaging velocities and conventional echocardiographic 
parameters.
Mean MVA Mean gradient Left atrium diameter PASP
r p r p r p r p
IVV 0.387 0.002 –0.260 0.042 –0.522 < 0.001 –0.565 < 0.001
IVA 0.185 0.150 –0.147 0.255 –0.368 < 0.001 –0.384 < 0.001
Sm 0.220 0.085 –0.190 0.138 –0.541 < 0.001 –0.537 < 0.001
e’ 0.348 0.006 –0.317 0.012 –0.687 < 0.001 –0.708 < 0.001
a’ 0.374 0.003 –0.243 0.057 –0.387 < 0.001 –0.493 < 0.001
MVA — mitral valve area; PASP — pulmonary artery systolic pressure; IVV — peak myocardial velocity during isovolumic contraction; IVA — 
myocardial acceleration during isovolumic contraction; Sm — peak myocardial velocity during systole; e’ — peak myocardial velocity during 
early diastole; a’ — peak myocardial velocity during atrial contraction
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measurement of the ventricular contractility (end-
-systolic elastance) requires invasive quantification 
[22], and most of the contractile indexes (e.g., EF, 
MPI, and TDI-derived velocities or strain) are 
highly sensitive to loading conditions, it is thought 
that they might not reflect the intrinsic myocardial 
performance [17, 23, 24].
Isovolumic acceleration is a new tissue Doppler 
parameter for the assessment of systolic function 
of both left and the right ventricles [13, 14]. It re-
mains unaffected by the changes in the preload and 
afterload within the physiological range [13–16] 
including age, sex and body mass index [25]. It 
can detect even small changes in the contractile 
function and is well correlated with the invasive 
or noninvasive measures of LV dP/dt [13, 17]. 
Therefore, IVA can be used as a valuable and easy 
parameter for the quantification of global systolic 
function in various cardiac diseases [26, 27].
The present study shows that isolated MS 
may lead to significant decrease of LV systolic and 
diastolic function. In the studies using TDI-derived 
parameters, systolic velocities were demonstrated 
to be significantly decreased in the healthy con-
trols, as consistent with our study [7–9]. Similar 
to the study by Sengupta et al. [8], Ozdemir et 
al. [9] demonstrated that early and late diastolic 
myocardial velocities were decreased in MS. On 
the other hand, Dogan et al. [28] did not find any 
differences compared to the controls. Decreased 
LV pre-load, impaired compliance and increased 
LA afterload are known changes in MS. LA size 
increases with the LA volume and pressure, and 
is associated with the initial gain in the contractile 
shortening. However, with progressive dilatation of 
the LA, which eventually leads to a threshold fiber 
length, atrial shortening and contractility begin to 
decline. Beyond the threshold, further enlarge-
ment will only result in the deterioration of atrial 
function. This theory was supported by decreased 
e’ and a’ velocities, and the presence of positive 
correlation between this decrease and MVA in our 
study. Previous study demonstrated that MPI and 
IVRT were increased and ET was shortened [29] 
in the patients with MS compared to the controls. 
In consistent with the previous studies, the pres-
ent study demonstrated that ET decreased as 
the severity of MS increased and, MPI and IVRT 
increased independently from the severity of MS.
Even though IVV, IVA and Sm velocities 
decrease in the patients with MS compared to the 
control group, this decrease is independent from 
the degree of MS. In addition, the fact that the sy-
stolic parameters such as IVA and Sm velocities are 
not correlated with MVA and the mean gradient, 
though weakly associated with IVV, indicates that 
the LV systolic dysfunction might be caused by 
an acute rheumatic fever leading to myocardial 
damage. The results of some studies [12, 30] were 
consistent with these findings in that the major 
determinant of the LV systolic dysfunction in iso-
lated MS is impaired contractility and not the he-
modynamic factors. Lee and Lee [12] evaluated the 
LV myocardium of 15 isolated MS patients using 
electron microscopy and demonstrated structural 
changes in LV independent from the EF and the 
degree of MS, determined by ECHO parameters. 
However, these patients with abnormal LV function 
always exhibit more extensive loss of myofibrils 
which results from either disproportion of the 
mitochondria-to-myofibril ratio or myofibrillar de-
generation. In the study of Bilen et al. [30], which 
investigated the LV systolic function of mild, mo-
derate and severe MS patients with preserved EF, 
using 2D speckle-tracking ECHO-derived strain; 
it was demonstrated that LV longitudinal function 
was decreased in patients with MS compared to the 
controls, however, this decrease was independent 
from the degree of MS. In our study, LV systolic 
function was evaluated globally with TDI-derived 
IVA and similar results were obtained. Furthermo-
re, the patients were more evenly distributed into 
the groups in the present study.
Tayyareci et al. [26] investigated the IVA of 
right ventricle in prediction of the degree of MS 
and demonstrated that Sm, IVV and IVA of right 
ventricle significantly decreased in the patients 
with MS compared to the control group, however, 
they noted that only right ventricle and IVA can 
predict the degree of MS. Decreased IVA of LV was 
shown in MS patients in our study, although it was 
not associated with the degree of stenosis. This 
discrepancy might be caused by the classification 
differences; since Tayyareci et al. [26] grouped 
the MS patients into two groups (mild-moderate 
and severe) instead of three (mild, moderate and 
severe), which was helpful in the assessment of 
treatment strategies. Besides, the correlation of 
IVA with both LA diameter and PASP might be 
resulted from the increase in these two parameters 
due to hemodynamic effects of stenosis, instead of 
the systolic dysfunction of LV.
Limitations of the study
The current study has some limitations. First, 
a small number of patients included in this study. 
Second, systolic function parameters were not 
compared with the parameters obtained from 
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cardiac catheterization and magnetic resonance 
imaging. Third, the potential change in the IVA of 
LV was not assessed following the percutaneous 
balloon valvuloplasty.
Conclusions
In the light of these results, it is demonstrated 
that subclinical LV systolic dysfunction is present 
in all of the patients with MS and this condition is 
not affected by the degree of MS determined by 
ECHO.
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